top of page

Asia Pacific Leukemia Consortium

Changing the
Status Quo of Leukemia

Coming Up:
4th APLC Summit Meeting

31 Oct-1  November 2026 | Hong Kong, China

Image by Simon Zhu

About Us

The Asia-Pacific Leukemia Consortium (APLC) is a not for profit initiative to improve the management of leukemia and related diseases in the Asia-Pacific (APAC) region. The group aims to address the growing threat of leukemia in APAC region through a collaborative approach to advance disease prevention, patient care, research, clinical trials, and education. 

Introduction

As the world’s population continues to rapidly grow and age, cancer incidence, prevalence and mortality are also on the rise. 

Despite the advancement in medical technology, drug development, cancer prevention strategies there remains a huge divide to bridge in terms of access to drugs, optimizing treatment, translating trial data for a heterogeneous real-world Asia-Pacific population.

Our Mission

To improve the management of leukemia and related diseases in Asia-Pacific through the collective collaboration of valued partners and a targeted approach to bench-to-bedside research, translation of real-world evidence and bio-resources.

Our Focus Areas

  • Clinical Trials

  • Disease Registry

  • Genetic & Tissue Repository

  • Education

  • Patient Advocacy & Care

Our Working Groups

  • Acute Myeloid Leukemia (AML)​

  • Acute Lymphoblastic Leukemia (ALL)​

  • Other Related Diseases (ORD)​

Prof Wang Jianxiang

Prof Wang Jianxiang

Institute of Hematology, Blood Disease Hospital

CHINA

President

Asia Pacific Leukemia Consortium

Prof Ng Soo Chin

Prof Ng Soo Chin

Subang Jaya Medical Center

MALAYSIA

Vice President

Asia Pacific Leukemia Consortium

Prof Goh Yeow Tee

Prof Goh Yeow Tee

Singapore General Hospital

SINGAPORE

Director

Asia Pacific Leukemia Consortium

Executive Committee

Key Appointment Holders

Prof Andrew Wei

Prof Andrew Wei

Peter MacCallum Cancer Centre and The Royal Melbourne Hospital

AUSTRALIA

Prof Eric Tse

Prof Eric Tse

Queen Mary Hospital

HONG KONG SAR, CHINA

Prof Junichiro Yuda

Prof Junichiro Yuda

National Cancer Center Hospital East

JAPAN

Dr Than Hein

Dr Than Hein

Singapore General Hospital

SINGAPORE

Prof Kim Hee Je

Prof Kim Hee Je

The Catholic University of Korea Seoul St. Mary's Hospital

SOUTH KOREA

A/Prof Ko Bor-Sheng

A/Prof Ko Bor-Sheng

National Taiwan University Cancer Center

TAIWAN, CHINA

Prof Suporn Chuncharunee

Prof Suporn Chuncharunee

Ramathibodi Hospital, Bangkok

THAILAND

Executive Committee

Other Members

Our 

Working Groups

  • Acute Myeloid Leukemia (AML)​

  • Acute Lymphoblastic Leukemia (ALL)​

  • Other Related Diseases (ORD)​

Our 

Focus Areas

  • Clinical Trials

  • Disease Registry

  • Genetic & Tissue Repository

  • Education

  • Patient Advocacy & Care

Our Mission

To improve the management of leukemia and related diseases in Asia-Pacific through the collective collaboration of valued partners and a targeted approach to bench-to-bedside research, translation of real-world evidence and bio-resources.

Dr Ashley Ng

Australia

Peter MacCallum Cancer Centre and The Royal Melbourne Hospital

Prof Stephen Mulligan

Australia

Royal North Shore Hospital, Sydney

Prof Jie Jin

China

1st Affiliated Hospital of Zhejiang University College of Medicine

Prof Li Jianyong

China

Jiangsu Province Hospital

Prof Qui Lugui

China

Institute of Haematology, Blood Disease Hospital

Prof Ting Liu

China

West China Hospital of Sichuan University

Prof Eric Tse Wai Choi

Hong Kong

University of Hong Kong

Prof S Fadilah S Abdul Wahid

Malaysia

UKM Medical Centre (UKMMC)

Prof Gan Gin Gin

Malaysia

University Malaya Medical Centre

Dr Haris Abdul Rahman

Malaysia

Subang Jaya Medical Centre

Dr Jerome Tan Tsen Chuen

Malaysia

Hospital Ampang, Selangor, Malaysia

Dr Melissa Ooi Gaik Ming

Singapore

National University Cancer Institute Singapore

Dr Than Hein

Singapore

Singapore General Hospital

Dr Yvonne Loh Su Ming

Singapore

Currie Oncology & Haematology

Prof Kim Hee-Je

South Korea

Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea

Prof Lee Je-Hwan

South Korea

University of Ulsan College of Medicine, Asan Medical Center,

Prof Hou Hsin-An

Taiwan, China

National Taiwan University Hospital

A/Prof Yeh Su-Peng

Taiwan, China

China Medical University Hospital

A/Prof Adisak Tantiworawit

Thailand

Chiang Mai University Hospital

Prof Lalita Norasetthada

Thailand

Chiang Mai University Hospital

Dr Pimjai Niparuck

Thailand

Ramathibodi Hospital

Dr Udomsak Bunworasate

Thailand

King Chulalongkorn Memorial Hospital

NAME

REGION

ORGANISATION

Honorary Members

Peter MacCallum Cancer Centre and The Royal Melbourne Hospital

Dr Lynette Chee

Australia

Peter MacCallum Cancer Centre

Dr Nisha Thiagarajah

Australia

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

Prof Hui Wei

China

Peking Union Medical College Hospital

Dr Jian Li

China

West China Hospital of Sichuan University

Prof Wu Yu

China

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

Dr Ying Wang

China

Nanfang Hospital, Southern Medical University

Prof Zhou Hongsheng

China

The First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital

Dr Zhu Xiaoyu

China

Queen Mary Hospital

Dr Carol Cheung Yuk Man

Hong Kong

University Malaya Medical Centre

Prof Bee Ping-Chong

Malaysia

Hospital Ampang, Selangor

Dr Ho Kim Wah

Malaysia

Gleneagles Hosp, KL

Dr Jay Suriar

Malaysia

Hospital Sultanah Aminah Johor Bahru

Dr Lim Soo Min

Malaysia

Penang General Hospital

Dr Tan Sui Keat

Malaysia

Tan Tock Seng Hospital

Dr Dheepa Christopher

Singapore

National University Cancer Institute Singapore

Dr Jen Wei Ying

Singapore

National University Cancer Institute Singapore

A/Prof Koh Liang Piu

Singapore

Singapore General Hospital

Dr Nurul Aidah Abdul Halim

Singapore

Tan Tock Seng Hospital

Dr Venkata Sreekanth Sampath

Singapore

Singapore General Hospital

Prof Wong Gee Chuan

Singapore

National University Cancer Institute Singapore

Dr Lui Pak Ling

Singapore

King Chulalongkorn University

A/Prof Chantana Polprasert

Thailand

Khon Kaen University Hospital

Dr Chinadol Wanitpongpun

Thailand

Chiang Mai University Hospital

A/Prof Thanawat Rattanathammethee

Thailand

Thammasat University Hospital

A/Prof Wasithep Limvorapitak

Thailand

NAME

REGION

ORGANISATION

Key Opinion Leaders

The 3rd APLC Summit opened with remarks by Prof. Goh Yeow Tee, Prof. Wang Jianxiang, and Prof. Ng Soo Chin, who welcomed delegates from across Asia-Pacific and reaffirmed the consortium’s mission: to bridge global scientific advancements with regionally grounded, practical solutions for leukemia care.

 

The 2025 Summit brought together international leaders including Prof. Robin Foà, Dr. Othman Al-Sawaf, Prof. Mark Levis, and Prof. Jane Apperley, whose contributions set the stage for discussions centered on precision medicine, diagnostic equity, and the evolving therapeutic landscape.

Explore this landmark event's highlights through our photo gallery and video recordings available here, or visit our YouTube channel for more. Should you encounter any viewing issues, please reach out to us at APLC contact for assistance . 

What's New?

Event Media Centre

Contact

Feel free to ask any questions or share your interests regarding our events. This will help us tailor our communication to better suit your needs. Rest assured, your information will be kept confidential and used solely to address your questions or requests.

Stay tuned for more information. We look forward to connecting with you and answering your queries.

Profession

Main Office:

c/o: Singapore General Hospital

Outram Road,

Singapore 169608

Phone : 

(65) 6326 6003

Email :

secretariat@APLCON.org

Website:

https://www.aplcon.org

Privacy Policy

Terms of Use

  • Facebook
  • YouTube

© 2023 Asia Pacific Leukemia Consortium

bottom of page